Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Claritev ( (CTEV) ) has issued an announcement.
On March 16, 2026, Claritev Corporation’s management team hosted its 2026 Investor Day in New York, using a detailed presentation to brief shareholders and analysts on its business and financial framework. The company highlighted its reliance on non-GAAP metrics, including EBITDA, adjusted EBITDA, levered free cash flow and an adjusted cash conversion ratio, to help investors assess its ability to service debt, evaluate operational performance and understand how effectively it converts earnings into cash.
Claritev also outlined extensive risk factors that could cause future results to differ from management’s expectations, ranging from client concentration and competitive pressures to U.S. healthcare system trends, regulatory changes, cybersecurity threats and financing constraints. By furnishing rather than filing the Investor Day materials, the company provided broader visibility into its strategy and risk profile without subjecting the presentation to the full liability framework of the U.S. securities laws.
The most recent analyst rating on (CTEV) stock is a Sell with a $15.00 price target. To see the full list of analyst forecasts on Claritev stock, see the CTEV Stock Forecast page.
Spark’s Take on CTEV Stock
According to Spark, TipRanks’ AI Analyst, CTEV is a Neutral.
The score is held down primarily by weak financial performance (ongoing net losses and negative equity) and a strongly bearish technical setup (below key moving averages with negative MACD). These are only partly offset by a relatively positive earnings-call outlook (raised guidance, strong renewals, and pipeline/ACV growth) and operating cash flow resilience.
To see Spark’s full report on CTEV stock, click here.
More about Claritev
Claritev Corporation operates in the U.S. healthcare services and technology sector, focusing on solutions that span the healthcare lifecycle. The company emphasizes data-driven offerings and financial performance metrics such as EBITDA, adjusted EBITDA, and levered free cash flow to demonstrate its operational efficiency and capital structure resilience.
Average Trading Volume: 242,444
Technical Sentiment Signal: Sell
Current Market Cap: $279.6M
See more data about CTEV stock on TipRanks’ Stock Analysis page.